Annual Meeting

Scientists see anti-aging potential in an invasive weed

Cocklebur extracts could protect skin, speed wound healing and ward off wrinkles
Anne Frances Johnson
March 29, 2023

The fruit of the cocklebur plant, which grows worldwide and is often considered a noxious weed, has antioxidant and anti-inflammatory components that could make it useful as a skin protectant, according to new research.

Researchers found that compounds in the species’ spiky fruits reduced damage from UVB exposure and sped wound healing in laboratory tests using cells and tissues. The cocklebur extracts also appear to influence the production of collagen, a protein that gives skin its elasticity and prevents wrinkles.

“We found that cocklebur fruit has the potential to protect the skin and help enhance production of collagen,” said Eunsu Song, a doctoral candidate at Myongji University in South Korea, who conducted the research with Myongji University Professsor Jinah Hwang. “In this regard, it could be an attractive ingredient for creams or other cosmetic forms. It will likely show a synergistic effect if it is mixed with other effective compounds, such as hyaluronic acid or retinoic acid, against aging.”

Xanthium (cocklebur) is native to the Americas and eastern Asia.

Song will present the new research at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, March 25–28 in Seattle.

Cocklebur is a plant native to Southern Europe, Central Asia and China that has spread worldwide, often found in moist or sandy areas such as roadside ditches and riverbanks. Its distinctive fruits, covered in stiff husks and burrs, have been used for centuries in traditional medicines for headache, stuffy nose, disorders of skin pigmentation, tuberculosis-related illness and rheumatoid arthritis. In recent years scientists have explored its potential use in treatments for rheumatoid arthritis and cancer.

The new study is the first to examine the fruit’s properties as a wound-healing agent and skin protectant. Researchers first studied the molecular properties of cocklebur fruit extracts and isolated particular compounds that could contribute to anti-oxidant and anti-inflammatory effects. They then used cell cultures and a 3D tissue model with properties similar to human skin to study how these compounds affect collagen production, wound healing and damage from UVB radiation.

The results showed that the cocklebur fruit extracts encouraged collagen production, sped wound healing and exerted a protective effect against UVB radiation. Comparing the bioactivity of cocklebur fruits grown in different places, the researchers found that fruits grown in South Korea had slightly higher anti-oxidant and anti-inflammatory properties and greater wound-healing activity than those grown in China.

Researchers cautioned that high doses of cocklebur fruit extract can be harmful and further research is needed to determine how to use it safely in cosmetic or pharmaceutical applications.

“In its burrs, cocklebur fruit also has a toxic constituent, carboxyatractyloside, which can damage the liver,” said Song. “Cocklebur showed a potential as a cosmetic agent by increasing collagen synthesis; however, it showed negative results with higher concentrations. Therefore, finding the proper concentration seems very important and would be key to commercializing cocklebur fruit extracts in cosmetics.”

Moving forward, the researchers plan to further study the biological mechanisms involved and conduct experiments in animal alternatives to explore ways to safely adapt cocklebur fruit extracts for use in cosmetic products.

Eunsu Song will present this research during the poster session from 4–5:30 p.m. PDT on Tuesday, March 28, in the Exhibit Hall of the Seattle Convention Center (abstract) (Poster Board No. 139). Contact the media team for more information or to obtain a free press pass to attend the meeting.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Anne Frances Johnson

Anne Frances Johnson is founder and lead science writer at Creative Science Writing based in Chapel Hill, North Carolina. 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Protein modifications drive lung cancer resistance
Journal News

Protein modifications drive lung cancer resistance

Nov. 6, 2025

New assay enriches protein modifications in a single process, enabling detection of key changes in drug-resistant lung cancer cells that may guide future therapies.

How antigen-processing proteins shape immunity
Journal News

How antigen-processing proteins shape immunity

Nov. 6, 2025

Researchers show how components of the antigen processing machinery shape the immunopeptidome, offering insights into immune regulation and cancer biology.

New chemical strategy boosts accuracy in proteomics
Journal News

New chemical strategy boosts accuracy in proteomics

Nov. 6, 2025

Researchers develop a methylamine-based method that nearly eliminates peptide overlabeling in proteomics, improving accuracy in protein identification and quantitation.

Understanding the roles of extracellular matrix and vesicles in valvular disease
Profile

Understanding the roles of extracellular matrix and vesicles in valvular disease

Oct. 30, 2025

MOSAIC scholar Cassandra Clift uses mass spectrometry and multiomics to study cardiovascular calcification and collagen dysregulation, bridging her background in bioengineering and biology to investigate extracellular vesicles and heart disease.

Lipid profiles reveal sex differences in type 2 diabetes
Journal News

Lipid profiles reveal sex differences in type 2 diabetes

Oct. 29, 2025

Researchers explored the lipid profiles of individuals with type 2 diabetes and identified potentially useful lipid biomarkers for this condition.

Serum lipids may predict early diabetes risk
Journal News

Serum lipids may predict early diabetes risk

Oct. 29, 2025

Researchers found that levels of two key fatty acids may predict worsening tolerance for glucose, independent of body fat and insulin levels. In turn, these fatty acids may serve as early T2D biomarkers.